Analysis of Patient Treatment Pathways in Schizophrenia

 

Enrollment: ONGOING

 

Study Purpose – Optimizing Antipsychotic Use in Schizophrenia

 

Health Analytics is conducting a retrospective analysis of administrative claims parallel to a prospective provider survey to evaluate and elucidate the antipsychotic prescription pathways used in the treatment of schizophrenia. Health Analytics has developed a survey for providers to assess provider knowledge, attitudes, and beliefs regarding antipsychotic medication, as well as the underlying factors that affect health practitioners’ medication prescription patterns. The data from this survey will be combined with the treatment pathways and associated patient outcomes identified through claims analyses to develop a claims-based algorithm to promote effective antipsychotic patient treatment matching.

 

Study Design— Retrospective Claims Analysis and Provider Survey

 

Health Analytics is working with a number of providers who are providing treatment to patients who have been diagnosed with Schizophrenia.  Multiple data sources will be secured for the study such as single payer administrative claims, provider survey data, and other healthcare claims databases. The longitudinal study includes a survey that will be completed by providers. Each survey takes approximately 20 minutes and may be completed via phone, fax, or online. This survey will ask providers to provide their knowledge and beliefs towards their treatment choices for schizophrenia.

 

Financial compensation is available for all participating providers. All providers will be given an honorarium in the form of a check once the survey has been completed and received by Health Analytics.

 

Enrollment - ONGOING

 

Health Analytics is currently recruiting healthcare practitioners (physicians, nurse practitioners, and physician’s assistants) to enroll in the survey portion of the study. This study has been approved by the Chesapeake Institutional Review Board.

 

Interested providers must confirm the following:

  • Treatment of patients who meet study inclusion criteria

  • Completion of a business associate agreement (BAA)

  • Completion of an independent contracting agreement (ICA)

  • Completion of an informed consent form

  • Agreement to complete the healthcare practitioner survey at a later date

 

Patient criteria must meet the following:

  • Diagnosis of schizophrenia (295.xx)

  • Currently prescribed one or more antipsychotic medication(s)

  • Aged 18 years or older

  • Commercially insured (Aetna preferred)

 

 

If you are interested in participating in this survey please contact Health Analytics:

 

Niesha Johnson

Study Coordinator

njohnson@healthanalytic.com

P. (410) 997-3314 x105

F. (410) 997-4545

 

9200 Rumsey Rd

Suite 215

Columbia, MD 21045

 

Back to Current Studies

© 2018 by Health Analytics, LLC    +1 (410) 997-3314    info@healthanalytic.com